J&J Green Paper and Sintesa Group Forge Strategic Partnership to Produce Eco-Friendly Paper Coating and Combat Global Plastic Waste
14.6.2023 15:30:00 EEST | Business Wire | Press release
J&J Green Paper, Inc. (JJGP), a Delaware USA corporation, announced a strategic, global partnership with Sintesa Group, a leading Indonesian strategic investment company with a legacy spanning over a century, committed to advancing sustainable growth through impact investments.
The joint venture will leverage the patented technology of JJGP and the unparalleled leadership of the Sintesa Group to build worldwide production capacity for JANUS®, an eco-friendly coating for paper packaging developed by JJGP that replaces polyethylene and its related environmental hazards.
JANUS is an all-natural moisture-proof coating used for paper packaging. Its recyclable, compostable, and repulpable technology can replace the polyethylene currently used in traditional paper products - a significant contributor to the global waste disposal issue and environmental detriment. JANUS is a biodegradable compound with a sustainable food value chain approach and various applications and advantages that align with Sintesa's philosophy.
"Sintesa's commitment to fostering sustainable growth that can benefit people and the planet perfectly aligns with our vision," says Rick Bulman, President of JJGP. "We are excited and ready to create tangible positive social changes in Indonesia and globally by promoting a novel solution to manage the environmental hazards of polyethylene."
Started as a family business that aspires to maintain its resilience in an ever-changing dynamic, Sintesa Group puts sustainability as a strategic imperative that guides its business transformation. Under the leadership of fourth-generation family member Abyasa Kamdani, Sintesa ensures its future investment is aligned with the company as it pursues its vision of becoming a Sustainable Excellence Company.
"We strive to work with forward-thinking partners that can help with viable solutions to create a more sustainable business landscape and, eventually, world," says Kamdani, Sintesa's Head of Business Development. "Through innovative high technology, creating a better future by striving for the balance of economics, social and environmental good is within our grasp. Together with JJGP, we will contribute to the green economy of the ASEAN countries by producing a revolutionary product while helping to support agriculture, manage environmental hazards and create greener jobs through strategic yet responsible investments."
Bulman acknowledged this effort, noting that the sustainable technology introduced in Indonesia is anticipated to drive development initiatives across the ASEAN region in the years ahead. He added that JJGP would soon unveil further advisory partnerships on a global scale aimed at supporting their objectives in the US, Asia, and other regions.
"JANUS' versatility will lead to a long list of products that will no longer sit in landfills for centuries," says Bulman. "That has always been our goal, and we are confident this venture will make a dramatic environmental impact sooner than consumers think."
About Sintesa Group:
Sintesa Group is a leading Indonesian strategic investment company committed to sustainable excellence. Starting as a family business in 1919, Sintesa Group (PT Widjajatunggal Sejahtera) has transformed into a professional holding company that focuses on building new business as well as developing new strategy partnerships with potential business players. Under 4 main business pillars, namely Property, Consumer Products, Industrial Products, and Energy, Sintesa Group manages more than 15 subsidiaries, with two of them being publicly listed companies registered at the Indonesia Stock Exchange. Sintesa Group incorporate SDGs into its business model and responsible business practice by developing its very own SDGs Roadmap: Sintesa for the Earth, in pursuing the achievement of its vision to become a Sustainable Excellence Company.
About J&J Green Paper
J&J Green Paper, Inc. is a Delaware USA corporation that has developed a breakthrough all-natural patented compound and process to moisture-proof paper that not only eliminates the petrochemicals found in standard paper and paper packaging that, upon decay, create greenhouse gases but that meets stringent EU community and nation-state standards eliminating single-use plastics. For more information, visit www.jjgreenpaper.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230613195492/en/
Contact information
Inka Prawirasasra
AVP Corporate Communications and Sustainability
Sintesa Group
inka.prawirasasra@sintesagroup.com
085282807879
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom